Shin, Su Ryon
Harvard Medical School,
United States
2025 Rank: 23,160
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 810 out of 156,020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23,160 | 25,310 |
| Total Cites | 2,627 | 2,771 |
| H-index | 29 | 30 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 355 | 363 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 774 | 812 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,002 | 2,078 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.33 |
| Self-Citation Percentage |
5.20%
|
|
Shin, Su Ryon
Brigham and Women's Hospital,
United States
2024 Rank: 26,768
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 860 out of 135,958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26,768 | 28,082 |
| Total Cites | 2,429 | 2,572 |
| H-index | 27 | 28 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 317 | 325 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 644 | 676 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,834 | 1,908 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.35 |
| Self-Citation Percentage |
5.56%
|
|
Shin, Su Ryon
Harvard Medical School,
United States
2023 Rank: 22,600
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 676 out of 117,692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22,600 | 23,683 |
| Total Cites | 2,667 | 2,921 |
| H-index | 28 | 29 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 433 | 463 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 756 | 822 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,935 | 2,036 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.43 |
| Self-Citation Percentage |
8.70%
|
|
Shin, Su Ryon
Harvard Medical School,
United States
2022 Rank: 32,177
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 920 out of 103,235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32,177 | 35,120 |
| Total Cites | 2,136 | 2,315 |
| H-index | 26 | 27 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 415 | 429 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 565 | 595 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,513 | 1,580 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.47 |
| Self-Citation Percentage |
7.73%
|
|
Shin, Su Ryon
Brigham and Women's Hospital,
United States
2021 Rank: 35,951
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 932 out of 89,177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35,951 | 38,954 |
| Total Cites | 3,168 | 3,475 |
| H-index | 32 | 33 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 669 | 707 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 841 | 900 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,236 | 2,381 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.46 |
| Self-Citation Percentage |
8.83%
|
|
Shin, Su Ryon
Harvard Medical School,
United States
2020 Rank: 38,677
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1,057 out of 75,210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38,677 | 38,878 |
| Total Cites | 2,140 | 2,460 |
| H-index | 26 | 28 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 488 | 549 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 551 | 622 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,540 | 1,662 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.48 |
| Self-Citation Percentage |
13.01%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.